outpatients
Item
out-patients
boolean
C0029921 (UMLS CUI [1])
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
atopy
Item
history of atopic disease
boolean
C0392707 (UMLS CUI [1])
perennial asthma
Item
history of perennial bronchial asthma for at least 6 months as defined by ats criteria
boolean
C0004096 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
short acting beta-2-agonist
Item
current use of only inhaled short acting beta-2-agonist as required (for at least 4 weeks prior to baseline period b0)
boolean
C2936789 (UMLS CUI [1])
stable asthma
Item
stable asthma, i.e. no exacerbation or relevant respiratory tract infection within 2 months prior to study start
boolean
C0004096 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
fev1
Item
fev1 ≥ 70% predicted
boolean
C0748133 (UMLS CUI [1])
hyperreactivity to amp
Item
hyperreactivity to amp (pc20fev1 < 25 mg/ml)
boolean
C0020517 (UMLS CUI [1])
good health with the exception of asthma
Item
good health with the exception of asthma
boolean
C0018759 (UMLS CUI [1,1])
C0205170 (UMLS CUI [1,2])
C0004096 (UMLS CUI [2])
smoking history
Item
non-smokers as well as ex-smokers with either = 10 pack-years or more than 6 months of smoking abstinence
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
C0337672 (UMLS CUI [3])
exclusion criteria
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
comorbidity limiting use of inhaled steroids
Item
concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids (e.g. lung tuberculosis)
boolean
C0586793 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
abnormal laboratory values
Item
clinically relevant abnormal laboratory values suggesting an unknown disease and requiring further clinical evaluation
boolean
C1254595 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
systemic steroids
Item
use of systemic steroids 4 weeks (injectable depot steroids 6 weeks) before entry into the baseline period, or more than 3 times during the last 6 months
boolean
C2825233 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
pregnancy or intention to become pregnant or lactation or lack of safe contraception
Item
pregnancy or intention to become pregnant during the course of the study, breast feeding, lack of safe contraception in heterosexually active female patients of child-bearing potential, or postmenopausal for less than one year
boolean
C0032961 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C1283828 (UMLS CUI [2,2])
C0700589 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0006147 (UMLS CUI [4])
C3831118 (UMLS CUI [5])
C0232970 (UMLS CUI [6])
copd or other relevant lung diseases
Item
copd (i.e. chronic bronchitis or emphysema) and/or other relevant lung diseases
boolean
C0024117 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
hypersensitivity to inhaled steroids
Item
known or suspected hypersensitivity to inhaled steroids or to the other excipients of the metered dose inhalers
boolean
C0020517 (UMLS CUI [1,1])
C2065041 (UMLS CUI [1,2])
immunotherapy
Item
immunotherapy within one month prior to b0 and/or during the entire study duration
boolean
C0021083 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])